Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
11.34
+0.26 (2.35%)
At close: May 12, 2025, 4:00 PM
11.90
+0.56 (4.94%)
After-hours: May 12, 2025, 7:58 PM EDT
Indivior Employees
As of December 31, 2024, Indivior had 1,051 total employees, including 1,030 full-time and 21 part-time employees. The number of employees decreased by 113 or -9.71% compared to the previous year.
Employees
1,051
Change (1Y)
-113
Growth (1Y)
-9.71%
Revenue / Employee
$1,113,225
Profits / Employee
-$58,991
Market Cap
1.39B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
INDV News
- 11 days ago - New Study Highlights Monthly SUBLOCADE® as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy - PRNewsWire
- 14 days ago - Indivior: Trying To Break Addiction - Seeking Alpha
- 18 days ago - Indivior PLC (INDV) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 18 days ago - Indivior Announces Q1 2025 Financial Results - PRNewsWire
- 2 months ago - Indivior Announces Further Changes to Board of Directors - PRNewsWire
- 2 months ago - UK's Indivior appoints Joe Ciaffoni as CEO - Reuters
- 2 months ago - Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer - PRNewsWire
- 2 months ago - Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection - PRNewsWire